go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Dermal Laboratories Limited

Dermal Laboratories Limited
Tatmore Place, Gosmore, Hitchin, Herts, SG4 7QR , UK
Telephone: +44 (0)1462 458 866
Fax: +44 (0)1462 420 565


Summary of Product Characteristics last updated on medicines.ie: 10/07/2007
SPC Exterol 5% w/w Ear Drops, Solution

Table of Contents

  • 1. NAME OF THE MEDICINAL PRODUCT
  • 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
  • 3. PHARMACEUTICAL FORM
  • 4. CLINICAL PARTICULARS
  • 4.1 Therapeutic indications
  • 4.2 Posology and method of administration
  • 4.3 Contraindications
  • 4.4 Special warnings and precautions for use
  • 4.5 Interaction with other medicinal products and other forms of interaction
  • 4.6 Pregnancy and lactation
  • 4.7 Effects on ability to drive and use machines
  • 4.8 Undesirable effects
  • 4.9 Overdose
  • 5. PHARMACOLOGICAL PROPERTIES
  • 5.1 Pharmacodynamic properties
  • 5.2 Pharmacokinetic properties
  • 5.3 Preclinical safety data
  • 6. PHARMACEUTICAL PARTICULARS
  • 6.1 List of excipient(s)
  • 6.2 Incompatibilities
  • 6.3 Shelf life
  • 6.4 Special precautions for storage
  • 6.5 Nature and contents of container
  • 6.6 Special precautions for disposal and other handling
  • 7. MARKETING AUTHORISATION HOLDER
  • 8. MARKETING AUTHORISATION NUMBER(S)
  • 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
  • 10. DATE OF REVISION OF THE TEXT


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

EXTEROL™ 5% w/w EAR DROPS, SOLUTION


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Urea Hydrogen Peroxide 5.0% w/w.

For a full list of excipients, see section 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Ear drops, solution.

Clear, straw-coloured viscous solution.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

As an aid in the removal of hardened ear wax.


Go to top of the page
4.2 Posology and method of administration

For adults, children and the elderly. Instil up to 5 drops into the ear. Retain drops in ear for several minutes by keeping the head tilted and then wipe away any surplus. Repeat once or twice daily for at least 3 to 4 days, or as directed by the physician.


Go to top of the page
4.3 Contraindications

Do not use if the eardrum is known or suspected to be damaged, in cases of dizziness, or there is or has been any other ear disorder (such as pain, discharge, inflammation, infection or tinnitus). Do not use within 2 to 3 days of syringing or after ill-advised attempts to dislodge wax using fingernails, cotton buds or similar implements, as such mechanical efforts can cause the ear's delicate inner lining to become damaged, inflamed or infected, whereupon the use of ear drops can be painful. Do not use where there is a history of ear problems, unless instructed to do so by a doctor. Do not use if sensitive to any of the ingredients.


Go to top of the page
4.4 Special warnings and precautions for use

Keep Exterol away from the eyes. Keep out of the reach of children. For external use only. Replace cap after use, and return bottle to carton.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Exterol should not be used at the same time as any other type of topical preparation in the ear.


Go to top of the page
4.6 Pregnancy and lactation

No known side-effects.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Due to the release of oxygen, patients may experience a mild, temporary effervescence in the ear. Stop usage if irritation or pain occurs. Instillation of ear drops can aggravate the painful symptoms of excessive ear wax, including some loss of hearing, dizziness and tinnitus. Very rarely, blurred vision and unpleasant taste have been reported. If patients encounter any of these problems, or if their symptoms persist or worsen, they should discontinue treatment and consult a doctor.


Go to top of the page
4.9 Overdose

No adverse effects.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

After insertion of the drops into the ear, the urea hydrogen peroxide complex liberates oxygen which acts to break up the hardened wax. The hydrogen peroxide component is also a cerumenolytic. Its action as an antiseptic, especially in sites with relative anaerobiosis is well known. The glycerol and urea assist in softening the wax, so that it may more easily be removed from the ear, either with or without syringing. The urea acts as a mild keratolytic, helping to reduce the keratin-load in the wax debris, thereby assisting penetration of the other components.


Go to top of the page
5.2 Pharmacokinetic properties

Exterol is intended only for the treatment of impacted wax in the external auditory canal. The ingredients of the formulation are therefore readily available for intimate contact with the affected area, as the drops are instilled into the ear and retained therein for several minutes by tilting the head.


Go to top of the page
5.3 Preclinical safety data

No special information.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipient(s)

8-Hydroxyquinoline; Glycerol.


Go to top of the page
6.2 Incompatibilities

Do not use concurrently with anything else in the ear.


Go to top of the page
6.3 Shelf life

24 months.

Discard 4 weeks after first opening.


Go to top of the page
6.4 Special precautions for storage

Store upright. Do not store above 25°C. Keep the bottle tightly closed. Keep the bottle in the outer carton.


Go to top of the page
6.5 Nature and contents of container

8 ml easy squeeze plastic dropper bottle with screw cap.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Dermal Laboratories Limited

Tatmore Place, Gosmore

Hitchin, Herts SG4 7QR, UK


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PA 278/9/1.


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

28 January 2007.


Go to top of the page
10. DATE OF REVISION OF THE TEXT

January 2007.



Link to this document from your website:
http://www.medicines.ie/medicine/4262/SPC/Exterol+5++w+w+Ear+Drops%2c+Solution/

Document Links

 
  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share

Active Ingredients

 
   Urea Hydrogen Peroxide

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo